The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - RiverD; Skyline Diagnostics; Theranovir
Honoraria - Ellipses Pharma; GlaxoSmithKline; Incyte; iOMEDICO; ISA Pharmaceuticals; MedImmune; MSD; Novartis; Pfizer; Polynoma; Sanofi; Skyline Diagnostics
Consulting or Advisory Role - Ellipses Pharma; GlaxoSmithKline; Incyte; iOMEDICO; ISA Pharmaceuticals; MedImmune; MSD; Novartis; Pfizer; Polynoma; Sanofi; Skyline Diagnostics
Speakers' Bureau - MSD
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Prognostic and predictive value of an immune-related adverse event among stage III melanoma patients included in the EORTC 1325/KEYNOTE-054 pembrolizumab versus placebo trial.
 
Alexander M. M. Eggermont
No Relationships to Disclose
 
Michal Kicinski
No Relationships to Disclose
 
Christian U. Blank
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); NanoString Technologies (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Mario Mandalà
Honoraria - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Roche/Genentech (Inst)
 
Georgina V. Long
Honoraria - Bristol-Myers Squibb; Merck; Pierre Fabre
Consulting or Advisory Role - Aduro Biotech; Array BioPharma; Bristol-Myers Squibb; Incyte; MERCK; Novartis; OncoSec; Pierre Fabre
Research Funding - BMS Brazil (Inst); Merck (Inst)
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; OncoSec
 
Stéphane Dalle
Employment - Sanofi Pasteur (I)
Stock and Other Ownership Interests - Sanofi Pasteur (I)
Consulting or Advisory Role - MSD
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Andrew Mark Haydon
Honoraria - Merck; Novartis
Consulting or Advisory Role - Novartis; Pierre Fabre
Speakers' Bureau - Merck; Novartis
 
Mikhail Lichinitser
No Relationships to Disclose
 
Muhammad Khattak
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Speakers' Bureau - Bristol-Myers Squibb; Merck; MSD
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD
 
Matteo S. Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Shahneen Kaur Sandhu
Honoraria - Amgen; Bristol-Myers Squibb; Merck; Merck Serono
Consulting or Advisory Role - Amgen
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche/Genentech
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Susana Puig
Consulting or Advisory Role - Almirall; Amgen; Isdin; Leo Pharma; Myriad Pharmaceuticals; Pierre Fabre; Roche; Sun Pharma
Speakers' Bureau - La Roche-Posay; Pierre Fabre; Roche; Sanofi
Research Funding - Almirall (Inst); Castle Biosciences (Inst); Leo Pharma (Inst); Novartis Canada Pharmaceuticals Inc (Inst)
Travel, Accommodations, Expenses - Almirall; Isdin
 
Paolo Antonio Ascierto
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Idera; Immunocore; Incyte; MedImmune; Merck Serono; Merck Sharp & Dohme; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Sandoz; Sanofi; Sun Pharma; Syndax; Ultimovacs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Clemens Krepler
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Nageatte Ibrahim
Employment - Merck
Stock and Other Ownership Interests - GlaxoSmithKline; Merck
 
Sandrine Marreaud
No Relationships to Disclose
 
Alexander Christopher Jonathan Van Akkooi
Consulting or Advisory Role - 4SC (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); MSD Oncology (Inst); Novartis (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Pierre Fabre; Roche
 
Stefan Suciu
No Relationships to Disclose